Please read and agree to the
terms and conditions
of this site.
I agree
The CEO news
/news
Clear filters and search
Format
photo
Tags
/hedge-funds-private-equity
/money
anti obesity medication
business finance
catalent
health medical pharma
hedge funds & private equity
lars fruergaard
lars fruergaard jorgensen
money
nordisk
novo nordisk
peptide hormones
peptide therapeutics
semaglutide
What
came
2
×
ceo
promising
2
×
stock
2
×
amycretin
announcement
best
big
buying
class
cnbc
comments
company’s
day
develop
disappointed
drug
experimental
fanfare
following
friday
fruergaard
gain
half
here’s
ipo
jørgensen
lars
later
loss
maker
management
market
medicine
new
nordisk
nordisk's
nordisk’s
novo
ozempic
Language
unset
Current search:
came
×
stock
×
promising
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}